Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2020
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2020
- December 20204 results available
- November 20201 results available
- October 20206 results available
- September 20205 results available
- August 20201 results available
- July 20204 results available
- June 20202 results available
- May 20207 results available
- April 20206 results available
- March 20202 results available
Displaying 1 - 15 of 38 items.
Bacitracin for Injection (50,000 IU per vial) and the Risk of Nephrotoxicity and Anaphylactic Reactions
AlertHealth professional risk communication | 2020-12-21
ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy
AlertHealth professional risk communication | 2020-12-15
Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane
AlertHealth professional risk communication | 2020-12-01
Unauthorized nicotine buccal pouches may pose serious health risks
AlertPublic advisory | 2020-11-02
Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs
AlertPublic advisory | 2020-10-30
Recalls of Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite
AlertPublic advisory | 2020-10-30
PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer
AlertHealth professional risk communication | 2020-10-27
LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer
AlertInformation update | 2020-10-27
Benzocaine-Containing Products and the Risk of Methemoglobinemia in Children under Two Years of Age
AlertHealth professional risk communication | 2020-10-22
An unauthorized biologic eye drop, Regener-Eyes Ophthalmic Solution, recalled after Edmonton clinic found to be importing and selling it
AlertPublic advisory | 2020-10-04
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-30
Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market
AlertPublic advisory | 2020-09-30
All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concerns
AlertPublic advisory | 2020-09-24
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
AlertHealth professional risk communication | 2020-09-15